Found: 6 articles

Article Edition
Moiseev S.V., Shchulkin A.V., Abalenikhina Yu.V., Mylnikov P.Yu., Yakusheva E.N., Khmelevsky M.S., Matsiyak M.V.
Double-blind, randomized, phase I trial comparing the pharmacokinetics and safety of agalsidase beta bioanaloguer (Fabagal®) and the original drug (Fabrazim®) in healthy volunteers
№3 / 2023
A.A. Ilyushkina, G.V. Baydakova, I.O. Bychkov, N.A. Buruleva, E.Yu. Zakharova
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation
№2 / 2020
T.V. Kirsanova, O.V. Khoroshkeeva, E.S. Kamyshova, N.V. Sharashkina, N.K. Tetruashvilli
Successful pregnancy in a patient with Fabry disease and predominant renal involvement
№1 / 2016
V.V. Fomin, A.A. Pulin, O.A. Aksenova, T.Yu. Kustova, S.S. Girina, S.V. Roschupkina, V.A. Kudravtsev, V.A. Varshavskii, E.P. Golitsina, I.V. Damulin, V.V. Panasiuk, N.A. Mukhin
Severe podocyte damage in asymptomatic patient with Fabry disease
№1 / 2012
V.V. Fomin, A.A. Pulin, V.V. Rameev, V.P. Sedov, A.D. Meshkov, S.V. Roschupkina, V.V. Panasiuk, L.V. Kozlovskaya, N.A. Moukhin
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
№5 / 2010
V.V. Fomin, A.A. Pulin
Nephropathy in Fabry disease: opportunities of dramatic prognosis improvement
№1 / 2010


Бионика Медиа